ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,263.20
      -1.69%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.345
      -0.33%
      Bitcoin
      93,554.86
      -0.99%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Medacta Group Sa (0A05) Quote

      Medacta Group Sa

      Medacta Group Sa (0A05)

      LSE
      87.145
      0.00
      (0.00%)
      Closed January 13 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      87.145
      Bid
      82.79
      Ask
      91.50
      Volume
      0.00
      0.00 Day's Range 0.00
      87.145 52 Week Range 87.145
      Market Cap
      1.743B
      Previous Close
      87.145
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      742
      Shares Outstanding
      20,000,000
      Dividend Yield
      -
      PE Ratio
      35.43
      Earnings Per Share (EPS)
      2.37
      Revenue
      510.78M
      Net Profit
      47.36M

      About Medacta Group Sa

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.medacta.ch
      Headquarters
      Mendrisio, Che
      Founded
      -
      Medacta Group Sa is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker 0A05. The last closing price for Medacta was CHF87.15. Over the last year, Medacta shares have traded in a share price range of CHF 87.145 to CHF 87.145.

      Medacta currently has 20,000,000 shares outstanding. The market capitalization of Medacta is CHF1.74 billion. Medacta has a price to earnings ratio (PE ratio) of 35.43.

      Ask ADVFN Intelligence (AI)

      0A05 Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10087.14587.14587.145164287.145DE
      40087.14587.14587.14560587.145DE
      120087.14587.14587.14574287.145DE
      260087.14587.14587.14547987.145DE
      520087.14587.14587.14564087.145DE
      1560087.14587.14587.145108087.145DE
      2600087.14587.14587.14590987.145DE

      0A05 - Frequently Asked Questions (FAQ)

      What is the current Medacta share price?
      The current share price of Medacta is CHF 87.145
      How many Medacta shares are in issue?
      Medacta has 20,000,000 shares in issue
      What is the market cap of Medacta?
      The market capitalisation of Medacta is CHF 1.74B
      What is the 1 year trading range for Medacta share price?
      Medacta has traded in the range of CHF 87.145 to CHF 87.145 during the past year
      What is the PE ratio of Medacta?
      The price to earnings ratio of Medacta is 35.43
      What is the cash to sales ratio of Medacta?
      The cash to sales ratio of Medacta is 3.29
      What is the reporting currency for Medacta?
      Medacta reports financial results in EUR
      What is the latest annual turnover for Medacta?
      The latest annual turnover of Medacta is EUR 510.78M
      What is the latest annual profit for Medacta?
      The latest annual profit of Medacta is EUR 47.36M
      What is the registered address of Medacta?
      The registered address for Medacta is STRADA REGINA 34, CASTEL SAN PIETRO, MENDRISIO, 6874
      What is the Medacta website address?
      The website address for Medacta is www.medacta.ch
      Which industry sector does Medacta operate in?
      Medacta operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0R0XTesla Inc
      $ 388.20
      (0.00%)
      		4.24k
      0JOQJd.com Inc
      $ 72.00
      (0.00%)
      		3.03k
      0HCIAlibaba Group Holding Ltd
      $ 81.10
      (0.00%)
      		2.3k
      0R1OAmazon.com Inc
      $ 217.50
      (0.00%)
      		1.67k
      0P4FFord Motor Co
      $ 9.665
      (0.00%)
      		1.67k

      Discussion

      View Full Feed
      sunspotter sunspotter 4 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 15 minutes ago
      Marc loved your ides
      tinojax tinojax 16 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 18 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 35 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 35 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 36 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 37 minutes ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 43 minutes ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 46 minutes ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 52 minutes ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 53 minutes ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 56 minutes ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 57 minutes ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 1 hour ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 1 hour ago
      He would smother any question with words.
      Shawonsarker84 Shawonsarker84 1 hour ago
      $HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



      https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
      HMBL XTIA
      chen1992 chen1992 1 hour ago
      https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

      https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
      TGLO
      FNM500K FNM500K 1 hour ago
      Oh noooooo.....
      FNMA
      StockItOut StockItOut 1 hour ago
      OTC filings and attorney statements. my error.

      Point that it is on you to prove your claim, that:
      "There's no contract employees. There's no production shafts."

      Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

      I
      BMXI
      Money4Nothing-M4N Money4Nothing-M4N 2 hours ago
      Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

      And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
      KBLB
      rx7171 rx7171 2 hours ago
      Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

      To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
      AVXL

      Your Recent History

      LSE
      0A05
      Medacta
      LSE
      GH77
      Morg.st.b.v 25
      LSE
      64BB
      Lloyds Bk.6.90%
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads